Neuland Laboratories Limited

NSEI:NEULANDLAB 株式レポート

時価総額:₹96.0b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Neuland Laboratories マネジメント

マネジメント 基準チェック /24

Neuland Laboratories'の CEO はDavuluri Raoで、 Aug2013年に任命され、 の在任期間は 10.83年です。 の年間総報酬は₹ 57.50Mで、 34.5%給与と65.5%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の3.3%を直接所有しており、その価値は₹ 2.75B 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と9.1年です。

主要情報

Davuluri Rao

最高経営責任者

₹57.5m

報酬総額

CEO給与比率34.5%
CEO在任期間10.8yrs
CEOの所有権3.3%
経営陣の平均在職期間3.8yrs
取締役会の平均在任期間9.1yrs

経営陣の近況

Recent updates

Neuland Laboratories' (NSE:NEULANDLAB) Upcoming Dividend Will Be Larger Than Last Year's

Jun 19
Neuland Laboratories' (NSE:NEULANDLAB) Upcoming Dividend Will Be Larger Than Last Year's

Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?

Jun 12
Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?

Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00

May 21
Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00

There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump

Apr 19
There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump

We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease

Apr 15
We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease

Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%

Feb 17
Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%

Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates

Feb 12
Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates

Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly

Jan 05
Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly

The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount

Nov 12
The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount

Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today

Oct 27
Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today

Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly

Aug 24
Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly

Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically

Aug 05
Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically

Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Jul 05
Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Jun 21
Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

May 14
Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?

May 12
Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?

Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly

Aug 30
Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly

I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut

Feb 23
I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut

The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically

Feb 03
The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically

Neuland Laboratories (NSE:NEULANDLAB) Has A Pretty Healthy Balance Sheet

Mar 15
Neuland Laboratories (NSE:NEULANDLAB) Has A Pretty Healthy Balance Sheet

Can You Imagine How Elated Neuland Laboratories' (NSE:NEULANDLAB) Shareholders Feel About Its 391% Share Price Gain?

Feb 28
Can You Imagine How Elated Neuland Laboratories' (NSE:NEULANDLAB) Shareholders Feel About Its 391% Share Price Gain?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Neuland Laboratories Limited (NSE:NEULANDLAB)

Feb 12
Don't Ignore The Fact That This Insider Just Sold Some Shares In Neuland Laboratories Limited (NSE:NEULANDLAB)

Neuland Laboratories Limited (NSE:NEULANDLAB) Just Reported And Analysts Have Been Lifting Their Price Targets

Feb 04
Neuland Laboratories Limited (NSE:NEULANDLAB) Just Reported And Analysts Have Been Lifting Their Price Targets

Neuland Laboratories Limited's (NSE:NEULANDLAB) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Feb 03
Neuland Laboratories Limited's (NSE:NEULANDLAB) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

CEO報酬分析

Neuland Laboratories の収益と比較して、Davuluri Rao の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

₹3b

Dec 31 2023n/an/a

₹3b

Sep 30 2023n/an/a

₹3b

Jun 30 2023n/an/a

₹2b

Mar 31 2023₹58m₹20m

₹2b

Dec 31 2022n/an/a

₹1b

Sep 30 2022n/an/a

₹831m

Jun 30 2022n/an/a

₹651m

Mar 31 2022₹30m₹15m

₹638m

Dec 31 2021n/an/a

₹593m

Sep 30 2021n/an/a

₹731m

Jun 30 2021n/an/a

₹742m

Mar 31 2021₹34m₹11m

₹806m

Dec 31 2020n/an/a

₹540m

Sep 30 2020n/an/a

₹384m

Jun 30 2020n/an/a

₹257m

Mar 31 2020₹22m₹10m

₹162m

Dec 31 2019n/an/a

₹321m

Sep 30 2019n/an/a

₹257m

Jun 30 2019n/an/a

₹216m

Mar 31 2019₹13m₹10m

₹164m

Mar 31 2018₹5m₹3m

₹121m

報酬と市場: Davuluriの 総報酬 ($USD 689.20K ) は、 Indian市場 ($USD 380.55K ) の同規模の企業の平均を上回っています。

報酬と収益: Davuluriの報酬は過去 1 年間で 20% 以上増加しました。


CEO(最高経営責任者

Davuluri Rao (49 yo)

10.8yrs

在職期間

₹57,500,000

報酬

Mr. Davuluri Sucheth Rao has been the Chief Executive Officer of Neuland Laboratories Limited since August 1, 2013, where Mr. Rao also served as its Chief Operating Officer. At Neuland, Sucheth has been re...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Davuluri Rama Rao
Executive Chairman & Chief Promoter40.4yrs₹60.00m26.37%
₹ 25.3b
Davuluri Rao
Vice Chairman & CEO10.8yrs₹57.50m3.3%
₹ 3.2b
Davuluri Rao
Vice Chairman & MD15yrs₹57.50m2.24%
₹ 2.1b
Abhijit Majumdar
Chief Financial Officer1.6yrsデータなしデータなし
Sharadsrikar Kotturi
Chief Scientific Officerless than a yearデータなしデータなし
Sarada Bhamidipati
Company Secretary & Compliance Officer12.4yrsデータなしデータなし
Y. Sudheer
Head of Marketingno dataデータなしデータなし
Shashank Mahashabde
President of Business Development & Contract Manufacturingno dataデータなしデータなし
Ashutosh Sinha
Chief Quality Officerless than a yearデータなしデータなし
Bharadwaj Gollapudi
Deputy General Managerno dataデータなしデータなし

3.8yrs

平均在職期間

55yo

平均年齢

経験豊富な経営陣: NEULANDLABの経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Davuluri Rama Rao
Executive Chairman & Chief Promoter40.4yrs₹60.00m26.37%
₹ 25.3b
Davuluri Rao
Vice Chairman & CEO20.9yrs₹57.50m3.3%
₹ 3.2b
Davuluri Rao
Vice Chairman & MD15yrs₹57.50m2.24%
₹ 2.1b
Prasad Menon
Independent Director1.6yrs₹1.74mデータなし
Homi Khusrokhan
Non-Executive Independent Director5.3yrs₹2.19mデータなし
Sugata Sircar
Independent Directorless than a yearデータなしデータなし
Christopher Cimarusti
Non-Executive Director14.7yrs₹1.75mデータなし
Nirmala Murthy
Non-Executive Independent Director9.1yrs₹2.11mデータなし
Pallavi Bakhru
Independent Directorless than a yearデータなしデータなし

9.1yrs

平均在職期間

78yo

平均年齢

経験豊富なボード: NEULANDLABの 取締役会経験豊富 であると考えられます ( 9.1年の平均在任期間)。